Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-08-21

FDA Approved: NORVIR — Supplemental Application (AbbVie Inc.)

View source ↗

Summary

The FDA approved AbbVie’s supplemental application for NORVIR (ritonavir). The approval updates the product’s labeling or uses as described in the submission.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Norvir (ritonavir)

Snippet

SUPPL AP for NORVIR (RITONAVIR)